| 产品详情 |
| Edit |   |
|---|
| Product Name | Tecovirimat |
|---|
| Description | An orally bioavailable antiviral agent; has activity against poxviruses expressing wild-type p37; inhibits the cytopathic effects induced by various strains of variola and monkeypox viruses in C. aethiops BSC40 kidney epithelial cells (EC50s = 0.019-0.067 and 0.023-0.039 µM, respectively) and decreases viral plaque size in a plaque formation assay at 0.05 µM; inhibits plaque formation by cowpox or vaccinia viruses in a plaque formation assay using human foreskin fibroblasts (EC50s = 0.48 and 0.05 µM, respectively); increases survival in cowpox and vaccinia virus-infected mice at 100 mg/kg per day for 14 days; increases survival of variola and monkeypox-challenged cynomolgus monkeys at 300 mg/kg per day for 14 days |
|---|
| Size | 1 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | CAS: 869572-92-9 |
|---|
| Catalog # | 26667-1 |
|---|
| Price | |
|---|
| Order / More Info | Tecovirimat from CAYMAN CHEMICAL COMPANY |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|